Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential

Multimorbidity is the major cause of ill-health and premature death in developed countries. The ability to identify individuals at risk of developing chronic disease, particularly multimorbidity, reliably, and simply, and to identify undiagnosed disorders, is vital to reducing the global burden of d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karen N. Barnett, Gavin R. C. Clark, Robert J. C. Steele, Callum G. Fraser
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2f009fec1977418d8c71529dea97c166
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2f009fec1977418d8c71529dea97c166
record_format dspace
spelling oai:doaj.org-article:2f009fec1977418d8c71529dea97c1662021-11-25T17:21:34ZFaecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential10.3390/diagnostics111120932075-4418https://doaj.org/article/2f009fec1977418d8c71529dea97c1662021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2093https://doaj.org/toc/2075-4418Multimorbidity is the major cause of ill-health and premature death in developed countries. The ability to identify individuals at risk of developing chronic disease, particularly multimorbidity, reliably, and simply, and to identify undiagnosed disorders, is vital to reducing the global burden of disease. This narrative review, the first of recent studies, demonstrates that raised faecal haemoglobin concentration (f-Hb) is associated with increased all-cause and cause-specific mortality and with longer-term conditions including diabetes, hypertension, cardiovascular disease, and psoriasis, and with probable intake of particulate matter. We and others have hypothesized that elevated f-Hb (measured using a faecal immunochemical test) has considerable potential to identify individuals at risk of, or who already have, early stage, undiagnosed chronic disease. If f-Hb does prove to be an effective biomarker for chronic disease and multimorbidity, individuals with detectable f-Hb, but without an obvious source of gastrointestinal blood loss, could benefit from further assessment and early intervention. To test this hypothesis rigorously, longitudinal data-linkage methodology is required linking colorectal cancer screening data, and data on patients presenting with lower gastrointestinal symptoms, with routinely collected health information.Karen N. BarnettGavin R. C. ClarkRobert J. C. SteeleCallum G. FraserMDPI AGarticlechronic diseasedata linkagefaecal haemoglobinfaecal immunochemical testinflammationmultimorbidityMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2093, p 2093 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic disease
data linkage
faecal haemoglobin
faecal immunochemical test
inflammation
multimorbidity
Medicine (General)
R5-920
spellingShingle chronic disease
data linkage
faecal haemoglobin
faecal immunochemical test
inflammation
multimorbidity
Medicine (General)
R5-920
Karen N. Barnett
Gavin R. C. Clark
Robert J. C. Steele
Callum G. Fraser
Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
description Multimorbidity is the major cause of ill-health and premature death in developed countries. The ability to identify individuals at risk of developing chronic disease, particularly multimorbidity, reliably, and simply, and to identify undiagnosed disorders, is vital to reducing the global burden of disease. This narrative review, the first of recent studies, demonstrates that raised faecal haemoglobin concentration (f-Hb) is associated with increased all-cause and cause-specific mortality and with longer-term conditions including diabetes, hypertension, cardiovascular disease, and psoriasis, and with probable intake of particulate matter. We and others have hypothesized that elevated f-Hb (measured using a faecal immunochemical test) has considerable potential to identify individuals at risk of, or who already have, early stage, undiagnosed chronic disease. If f-Hb does prove to be an effective biomarker for chronic disease and multimorbidity, individuals with detectable f-Hb, but without an obvious source of gastrointestinal blood loss, could benefit from further assessment and early intervention. To test this hypothesis rigorously, longitudinal data-linkage methodology is required linking colorectal cancer screening data, and data on patients presenting with lower gastrointestinal symptoms, with routinely collected health information.
format article
author Karen N. Barnett
Gavin R. C. Clark
Robert J. C. Steele
Callum G. Fraser
author_facet Karen N. Barnett
Gavin R. C. Clark
Robert J. C. Steele
Callum G. Fraser
author_sort Karen N. Barnett
title Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
title_short Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
title_full Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
title_fullStr Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
title_full_unstemmed Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
title_sort faecal haemoglobin estimated by faecal immunochemical tests—an indicator of systemic inflammation with real clinical potential
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2f009fec1977418d8c71529dea97c166
work_keys_str_mv AT karennbarnett faecalhaemoglobinestimatedbyfaecalimmunochemicaltestsanindicatorofsystemicinflammationwithrealclinicalpotential
AT gavinrcclark faecalhaemoglobinestimatedbyfaecalimmunochemicaltestsanindicatorofsystemicinflammationwithrealclinicalpotential
AT robertjcsteele faecalhaemoglobinestimatedbyfaecalimmunochemicaltestsanindicatorofsystemicinflammationwithrealclinicalpotential
AT callumgfraser faecalhaemoglobinestimatedbyfaecalimmunochemicaltestsanindicatorofsystemicinflammationwithrealclinicalpotential
_version_ 1718412460225986560